A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

Clinical trial NCT00976391 · COMPLETED

Trial details

NCT number: NCT00976391
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2009-09-01
Primary completion: 2011-10-01
Enrollment: 586

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.